The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Silencing of genes required for glycosylphosphatidylinositol anchor biosynthesis in Burkitt lymphoma.
Rong Hu; Galina L Mukhina; Soo Hee Lee; Richard J Jones; Paul T Englund; Patrick Brown; Saul J Sharkis; J Thomas Buckley; Robert A Brodsky (Profiled Authors: Robert Brodsky; Richard Jones; Rong Hu; Saul Sharkis; Patrick Brown; Paul Englund)
Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA.
Experimental hematology 2009;37(4):423-434.e2.
OBJECTIVE: To investigate the mechanism of glycosylphosphatidylinositol (GPI) anchor deficiency in Burkitt lymphoma cell lines. METHODS: We identified a large GPI anchor protein deficient population in three different Burkitt lymphoma cell lines through proaerolysin treatment of the cells and flow cytometry analysis using a proaerolysin variant (FLAER). The mechanism of GPI anchor protein deficiency was studied by DNA gene sequencing, a cell-free assay to investigate the GPI anchor biosynthetic pathway, microarray analysis, and quantitative real-time polymerase chain reaction. RESULTS: Burkitt lymphoma cell lines harbor large populations of FLAER(neg) cells, which are resistant to proaerolysin. In all three cell lines, silencing of a gene involved in an early step in GPI-anchor biosynthesis was responsible for the lack of GPI-anchored proteins on the cell surface. Quantitative polymerase chain reaction and microarray analysis demonstrate that the level of mRNA for PIGL and PIGY is lower in the FLAER(neg) Ramos cells and that mRNA levels of PIGY are reduced in the Akata and Daudi cells. Hypermethylation of these genes was associated with the low levels of mRNA and treatment of the cells with 5-aza-2' deoxycytidine restored cell surface GPI-anchored proteins to the FLAER(neg) cells. CONCLUSION: GPI-anchored protein deficiency in Burkitt lymphoma cells is not due to a genetic mutation (e.g., PIGA); rather, the lack of GPI-anchored proteins results from transcriptional silencing of PIGL and PIGY.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Marcin Kortylewski; Maciej Kujawski; Tianhong Wang; Sheng Wei; Shumin Zhang; Shari Pilon-Thomas; Guilian Niu; Heidi Kay; James Mulé; William G Kerr; et al.Nature medicine 2005;11(12):1314-21.
Jianming Ying; Zifen Gao; Hongyu Li; Gopesh Srivastava; Paul G Murray; Hwee Koon Goh; Chai Yen Lim; Yajun Wang; Teresa Marafioti; David Y Mason; et al.British journal of haematology 2007;136(6):829-32.
Guibin Chen; Zhaohui Ye; Xiaobing Yu; Jizhong Zou; Prashant Mali; Robert A Brodsky; Linzhao ChengCell stem cell 2008;2(4):345-55.
Appears in this Publication
Author of this Publication